What to do if lapatinib is resistant
Lapatinib is a dual kinase inhibitor targeting HER2 and EGFR and has shown significant efficacy in the treatment of HER2-positive breast cancer. However, with the prolongation of treatment time, some patients may develop resistance to lapatinib, resulting in weakened or even ineffective treatment effects.
Once a patient develops resistance to lapatinib, he or she needs to stay calm and communicate with the doctor in a timely manner. The doctor will develop a personalized treatment plan based on the patient's specific situation. Possible treatment strategies include replacing other targeted drugs, combining other anti-tumor drugs, using immunotherapy, etc.
In terms of changing drugs, doctors may consider using otherHER2-targeted drugs, such as pyrotinib, T-DM1, etc. These drugs may have different mechanisms of action and can bypass the resistance pathway of lapatinib. In addition, the combined use of chemotherapy drugs, immunotherapy, etc. may also enhance the therapeutic effect and delay the development of drug resistance.
It is worth noting that the development of lapatinib resistance is often related to a variety of factors, including genetic mutations in tumor cells and changes in drug metabolism pathways. Therefore, during the treatment process, doctors may recommend that patients undergo genetic testing to understand the genetic mutations of tumor cells and provide a basis for formulating more precise treatment plans.
In addition, patients should also pay close attention to their physical reactions while using lapatinib. Once any symptoms of discomfort occur, such as nausea, vomiting, diarrhea, rash, etc., they should contact their doctor in time so that the treatment plan can be adjusted in a timely manner.
In short, when facing the situation of lapatinib resistance, patients should not panic too much, but should actively cooperate with the doctor's treatment suggestions and adopt appropriate treatment strategies in order to obtain better treatment effects. At the same time, maintaining a positive attitude and good living habits are also important factors in defeating the disease.
xa0
Reference: https://pmc.ncbi.nlm.nih.gov/articles/PMC6180577/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)